ArticleArthroplasty (London, England)2026
Quadriceps muscle status after medial-pivot versus ultracongruent total knee arthroplasty using localized bioimpedance analysis: a randomized exploratory study.
Article in Arthroplasty (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundImplant design in total knee arthroplasty (TKA) may influence postoperative biomechanics and muscle recovery. Ultracongruent (UC) and medial pivot (MP) designs aim to enhance anteroposterior stability and reproduce physiological knee kinematics, yet comparative data remain scarce, and muscle recovery has rarely been directly evaluated. Localized bioelectrical impedance analysis (L-BIA) provides an objective method to assess skeletal muscle status, but its application to compare muscle recovery between different TKA implant designs has not been previously investigated.
methodsA prospective, randomized, patient-blinded study was conducted between 2022 and 2024, including 40 patients undergoing primary TKA for advanced knee osteoarthritis. Patients were randomly assigned to receive either a medial-pivot (MP) or an ultracongruent (UC) prosthesis. The final analysis included 30 patients (15 per group). The primary outcome was postoperative quadriceps muscle recovery between implant groups, assessed longitudinally by reactance (Xc) of the rectus femoris, vastus medialis, and vastus lateralis using localized bioelectrical impedance analysis (L-BIA). Assessments were performed preoperatively and at 6 and 12 months postoperatively. Secondary outcomes included resistance (R), WOMAC, Knee Society Score, range of motion, and radiographic parameters. Temporal changes and between-group differences were analysed using repeated-measures and covariance-based statistical models.
resultsDemographic and preoperative characteristics were comparable between groups. Resistance values remained stable across all time points with no differences between implant designs. Reactance showed a transient decrease at 6 months followed by recovery at 12 months in both groups, with no significant differences between groups. ANCOVA demonstrated that baseline reactance was associated with 12-month reactance values (all p < 0.001), whereas implant design had no significant effect. The clinical relevance of this finding remains uncertain. Radiographic parameters, postoperative range of motion, and clinical outcomes improved significantly after surgery in both groups without significant differences between MP and UC designs.
conclusionNo significant differences in quadriceps recovery were observed between MP and UC implants during the first postoperative year. Baseline muscle status was associated with postoperative L-BIA outcomes, whereas no significant differences were observed between implant designs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.